CompletedEarly Phase 1ketamine

EEG Characteristics in ECT

Sponsored by University of New Mexico

NCT ID
NCT04022226
Target Enrollment
11 participants
Start Date
2019-10-01
Est. Completion
2020-10-01

About This Study

The investigators will be examining slow-wave characteristics in depressed patients receiving electroconvulsive therapy (ECT) using direct current electroencephalogram (dcEEG) by anesthesia induction agent.

Conditions Studied

Electroconvulsive TherapyDirect Current ElectroencephalogramKetamineSpreadind Depression

Interventions

  • Ketamine
  • Methohexital

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Structured Clinical Interview for DSM-5 will confirm diagnosis of MDD or BPD-depressed (with or without psychotic features
* The clinical indications for ECT including treatment resistance or a need for a rapid and definitive response;
* Hamilton Depression Rating Scale 24-item (HDRS-24) \> 21; and
* Age range between 18 and 65 years of age.

Exclusion Criteria:

* Defined neurological or neurodegenerative disorder (e.g., history of head injury with loss of consciousness \> 5 minutes, epilepsy, Alzheimer's disease);
* Other psychiatric conditions (e.g., schizophrenia, schizoaffective disorder, bipolar disorder)
* Current drug or alcohol use disorder, except for nicotine and marijuana
* Adults unable to consent, pregnant women, prisoner
* Non-English speakers
* Patients that cannot tolerate Methohexital and Ketamine.

Study Locations (1)

University of New Mexico Mental Health Center
Albuquerque, New Mexico, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

EEG Characteristics in ECT | Huxley